Gastrointestinal safety profile of nabumetone: a meta-analysis (Q33421372)

26 July 2017

0 references

Gastrointestinal safety profile of nabumetone: a meta-analysis (English)

1 reference

26 July 2017

1 reference

J Q Huang

1

1 reference

26 July 2017

S Sridhar

series ordinal

2

1 reference

26 July 2017

R H Hunt

series ordinal

3

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 December 1999

1 reference

American Journal of Medicine

26 July 2017

published in

1 reference

26 July 2017

volume

107

1 reference

26 July 2017

issue

6A

1 reference

26 July 2017

page(s)

55S-61S; discussion 61S-64S

1 reference

Trends in the utilization of non-steroidal anti-inflammatory drugs in the United States, 1986-1990

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900368-X

Optimal assessment of gastrointestinal side effects induced by non-steroidal anti-inflammatory drugs. Endoscopic lesions, faecal blood loss, and symptoms not necessarily correlated, as observed after naproxen and oxindanac in healthy volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900368-X

The effect of nonsteroidal antiinflammatory drugs on upper gastrointestinal tract symptoms and mucosal integrity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900368-X

Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory Drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900368-X

Variability in the risk of major gastrointestinal complications from nonaspirin nonsteroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900368-X

Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900368-X

Nonsteroidal anti-inflammatory drug-related gastrointestinal toxicity: definitions and epidemiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900368-X

Novel oral drug formulations. Their potential in modulating adverse effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900368-X

Comparing analgesic efficacy of non-steroidal anti-inflammatory drugs given by different routes in acute and chronic pain: a qualitative systematic review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900368-X

Nabumetone. A reappraisal of its pharmacology and therapeutic use in rheumatic diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900368-X

Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900368-X

Safety experience with nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in osteoarthritis and rheumatoid arthritis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900368-X

Review of the experience with nabumetone in clinical trials outside of the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900368-X

Nabumetone in the treatment of skin and soft tissue injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900368-X

Safety evaluation of nabumetone in United States clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900368-X

Nonsteroidal antiinflammatory drugs, ulcers and risk:A collaborative meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900368-X

Safety profiles of leading nonsteroidal anti-inflammatory drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900368-X

Review: The Biochemical Basis of Non-Steroidal Anti-Inflammatory Drug-Induced Damage to the Gastrointestinal Tract: A Review and a Hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900368-X

Radiochromium (chromium-51) evaluation of gastrointestinal blood loss associated with placebo, aspirin, and nabumetone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900368-X

Intestinal permeability and inflammation in patients on NSAIDs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900368-X

10.1016/S0002-9343(99)00368-X

7 January 2021

Identifiers

DOI

1 reference

26 July 2017

1 reference